Ameritas Investment Partners
ADPT icon

Ameritas Investment Partners’s Adaptive Biotechnologies ADPT Stock Holding History

Ameritas Investment Partners’s Portfolio ADPT Stock Details ADPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$300K Buy
13,987
+1,502
+12% +$23K 0.01% 1139
2026
Q1 		$173K Hold
12,485
– – 0.01% 1349
2025
Q4 		$203K Hold
12,485
– – 0.01% 1247
2025
Q3 		$187K Sell
12,485
-2,773
-18% -$33.8K 0.01% 1280
2025
Q2 		$178K Buy
15,258
+3,972
+35% +$36.1K 0.01% 1370
2025
Q1 		$83.9K Hold
11,286
– – ﹤0.01% 1820
2024
Q4 		$67.7K Hold
11,286
– – ﹤0.01% 2007
2024
Q3 		$57.8K Hold
11,286
– – ﹤0.01% 2103
2024
Q2 		$40.9K Hold
11,286
– – ﹤0.01% 2248
2024
Q1 		$36.2K Hold
11,286
– – ﹤0.01% 2305
2023
Q4 		$55.3K Hold
11,286
– – ﹤0.01% 2117
2023
Q3 		$61.5K Buy
11,286
+2,924
+35% +$19.3K ﹤0.01% 1971
2023
Q2 		$56.1K Hold
8,362
– – ﹤0.01% 1977
2023
Q1 		$73.8K Hold
8,362
– – ﹤0.01% 1732
2022
Q4 		$78.6K Hold
8,362
– – ﹤0.01% 1759
2022
Q3 		$59K Hold
8,362
– – ﹤0.01% 1854
2022
Q2 		$67K Buy
+8,362
New +$73.5K ﹤0.01% 1787

Other funds holding ADPT

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Ameritas Investment Partners's ADPT Position: Q2 2026 in Review

Ameritas Investment Partners increased its Adaptive Biotechnologies (ADPT) stake by 12% in Q2 2026, buying an estimated $23K and bringing the position to 13,987 shares worth $300K. The position accounts for 0.01% of the portfolio, ranked #1139.

Ameritas Investment Partners first reported a position in ADPT in Q2 2022 and has held it in 17 quarters since. 300 funds tracked by Wall St. Rank hold ADPT as of Q2 2026.

  • Ameritas Investment Partners held 13,987 shares of Adaptive Biotechnologies worth $300K as of Q2 2026.
  • Ameritas Investment Partners bought 1,502 Adaptive Biotechnologies shares in Q2 2026, an estimated $23K.
  • Adaptive Biotechnologies made up 0.01% of Ameritas Investment Partners's portfolio in Q2 2026, its #1139 holding.
  • Ameritas Investment Partners first reported a position in Adaptive Biotechnologies in Q2 2022 and has held it in 17 quarters since.
  • 300 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q2 2026.

Based on Ameritas Investment Partners's 13F filing for Q2 2026, filed 13 Aug 2026.